To ensure rapid access by women in developing countries to any product that might prove successful in IPM’s Phase III trials, IPM initiated an Access Strategy, with dapivirine ring as a relevant case study. The plan builds on IPM’s Strategic Plan 2011-2015 and will serve as a guide for IPM on how to continue to direct attention to critical-path activities through product development and launch (2011-2018).
International Partnership for Microbicides. Preparing for Access to Microbicides and the Dapivirine Ring for HIV Prevention: Preliminary Strategy. International Partnership for Microbicides, Maryland, USA (2011) 37 pp.